INNOVATOR AND BIOSIMILAR INFLIXIMAB: COMPARABILITY ASSESSMENT OF THE HOST CELL PROTEINS AND PROTEIN HIGHER ORDER STRUCTURE Catalin Doneanu1, Jing Fang1, Alain Beck2, Weibin Chen1 and Ying Qing Yu1 1 Waters Corporation, Milford MA, 2Institute de Recherche Pierre Fabre, Centre d'Immunologie,…
Key words
cdrs, hdx, biosimilar, chain, host, inflixmimab, heavy, inflectra, displayed, hos, proteins, fractional, light, innovator, randomly